AzTrials
AzTrials

IntubationInSizeS25NCT03339141

Comparison of Intubating Conditions in 25° Head-up Position and Strict Supine

A study testing Intubation position in people with Intubation and Intratracheal, run by University Hospital, Clermont-Ferrand at 6 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Tracheal intubation, particularly before surgery, is traditionally done in supine position. It was shown in the general population and in obese patients in particular, that the pre-oxygenation in a 25° head-up position provided a better efficiency of the pre-oxygenation and an apnea time longer. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intubation, Intratracheal
What is being tested?
Intubation position
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
1,000 participants
Where
6 sitesFrance
Study dates
29 Nov 2017to 19 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • - patients scheduled for various surgeries requiring general anesthesia with curare, with intubation of the trachea, eligible for intubation by direct laryngoscopy.
  • > 18 years
  • patients with social security

Who cannot join

  • Emergency surgery.
  • Patient who requiring rapid sequence induction.
  • Intubation without curare.
  • Expected difficult intubation with planned modification of the intubation protocol (i. e. intubation under fibroscopy, airtrach or videolaryngoscopy)
  • Patient with a history of epilepsy, pulmonary or cardiovascular disease (including ischemic heart disease, symptomatic asthma or obstructive pulmonary disease).
  • Patient with mask phobia.
Show all 9Show fewer
  • BMI> 30kg / m2
  • Patient who are refusing to take part.
  • Patient protected major, minor, pregnant women, patients deemed incapable of giving informed consent.

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

France6 sites
  • CHU Clermont-Ferrand

    Clermont-Ferrand, 63003

  • Pôle Santé République

    Clermont-Ferrand

  • Centre Hospitalier Alpes-Léman

    Contamine-sur-Arve

  • Polyclinique Saint Odilon

    Moulins, 03000

  • Hôpital Saint-Louis / AP-HP

    Paris

  • Hôpital Nord-Ouest

    Villefranche-sur-Saône

Other trials in France

About this study

Tracheal intubation, particularly before surgery, is traditionally done in supine position. It was shown in the general population and in obese patients in particular, that the pre-oxygenation in a 25° head-up position provided a better efficiency of the pre-oxygenation and an apnea time longer. This position would also allow for better intubation conditions in direct laryngoscopy.

The investigators intend to assess two different patient's intubation position : supine position and 25° head-up position

Read the detailed description

Randomization assigned in random block, stratification by operator (20 patients per operator, 10 in each group).

Interim analysis every 100 patients.

Being tested
Intubation position
Keywords
Intubation conditions, Anaesthetic techniques, Laryngoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intubation positionProcedure or surgery

    The investigators assess two different patient's intubation position : supine position and 25° head-up position looking at the intubation score (POGO score).

Study groups in NCT03339141
Study groupRoleWhat they receive
supine positionPlacebo comparatorPatients are placed in the supine position at 0° from arrival in the room until intubation
Receives: Procedure: Intubation position
25° head-up positionActive comparatorPatients are placed in the 25° head-up position (half-seat or whole body proclive) from arrival in the room until intubation.
Receives: Procedure: Intubation position

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. POGO score

    valid score observed by the anesthetist performing intubation at the time of intubation. POGO score means Percentage of Glottic Opening : from 0% (none visualization of the glottic opening, worst result) to 100% (complete visualization of the glottic opening, best result), from the anterior curvature of the vocal cords to the interarytenoid node, between the posterior cartilage

    Measured: at day 1

Secondary outcomes (5)
  1. Cormack-Lehane grade

    another valid score observed by the anesthetist performing intubation at the time of intubation. It classifies views obtained by direct laryngoscopy based on the structures seen. From 1 (best result) to 4 (worst result). 1 : full view of glottis (POGO 100%) / 2 : partial view of glottis / 3 : only epiglottis seen, none of glottis seen (POGO 0%) / 4 : Neither glottis nor epiglottis seen (POGO 0%).

    Measured: at day 1

  2. Intubation operator's comfort

    visual analog scale about the operator's comfort during intubation. It's a subjective score. It's an evaluation of the comfort of the intubation position from 0 to 10, where 0 is a total discomfort, a painful, very uncomfortable position and 10 is an optimal, very comfortable position.

    Measured: at day 1

  3. Episodes of desaturation and episodes of hypotension

    SpO2 <90% or MAP <65mmHg or drop> 20% of the patient's baseline SBP

    Measured: at ady 1

  4. Mechanical complications of intubation:

    laryngeal pain, hoarseness, upper airway trauma

    Measured: at day 1

  5. Patient height

    at the tragus of the ear during intubation.

    Measured: at day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2017
  2. Study start29 Nov 2017
  3. Primary completion18 Sep 2021
  4. Study completion19 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03339141
Sponsor's protocol ID
CHU-361
Other IDs
2016-A02078-43
Acronym
InSizeS25
Status last verified
Oct 2021
First submitted
8 Nov 2017
Last updated
22 Oct 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Falempin AS, Pereira B, Binakdane F, Bazin JE, Smirdec M. Investigator-initiated, multicentre, open-label, two-arm, randomised controlled trial comparing intubating conditions in 25 degrees head-up position and supine: the InSize25 study protocol. BMJ Open. 2019 Nov 3;9(11):e029761. doi: 10.1136/bmjopen-2019-029761.

    PubMed 31685496

Questions about this trial

What is this clinical trial studying?

A study testing Intubation position in people with Intubation and Intratracheal, run by University Hospital, Clermont-Ferrand at 6 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

POGO score (time frame: at day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03339141, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in